Rafferty Asset Management’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $251K | Sell |
6,980
-2,943
| -30% | -$106K | ﹤0.01% | 1010 |
|
|
2025
Q1 | $309K | Sell |
9,923
-4,156
| -30% | -$129K | ﹤0.01% | 956 |
|
|
2024
Q4 | $359K | Sell |
14,079
-1,748
| -11% | -$44.6K | ﹤0.01% | 987 |
|
|
2024
Q3 | $448K | Buy |
15,827
+847
| +6% | +$24K | ﹤0.01% | 960 |
|
|
2024
Q2 | $395K | Sell |
14,980
-1,722
| -10% | -$45.4K | ﹤0.01% | 1012 |
|
|
2024
Q1 | $507K | Buy |
16,702
+2,365
| +16% | +$71.8K | ﹤0.01% | 975 |
|
|
2023
Q4 | $403K | Buy |
14,337
+1,737
| +14% | +$48.8K | ﹤0.01% | 1012 |
|
|
2023
Q3 | $342K | Buy |
12,600
+2,841
| +29% | +$77.1K | ﹤0.01% | 1002 |
|
|
2023
Q2 | $300K | Buy |
9,759
+1,798
| +23% | +$55.3K | ﹤0.01% | 1040 |
|
|
2023
Q1 | $287K | Buy |
7,961
+866
| +12% | +$31.2K | ﹤0.01% | 1048 |
|
|
2022
Q4 | $280K | Buy |
7,095
+1,468
| +26% | +$58K | ﹤0.01% | 1032 |
|
|
2022
Q3 | $226K | Sell |
5,627
-229
| -4% | -$9.2K | ﹤0.01% | 1069 |
|
|
2022
Q2 | $246K | Sell |
5,856
-5,553
| -49% | -$233K | ﹤0.01% | 993 |
|
|
2022
Q1 | $444K | Sell |
11,409
-11,524
| -50% | -$448K | ﹤0.01% | 1037 |
|
|
2021
Q4 | $914K | Buy |
22,933
+3,016
| +15% | +$120K | ﹤0.01% | 917 |
|
|
2021
Q3 | $720K | Buy |
19,917
+8,704
| +78% | +$315K | ﹤0.01% | 958 |
|
|
2021
Q2 | $460K | Buy |
11,213
+3,060
| +38% | +$126K | ﹤0.01% | 1088 |
|
|
2021
Q1 | $356K | Sell |
8,153
-3,249
| -28% | -$142K | ﹤0.01% | 1042 |
|
|
2020
Q4 | $571K | Buy |
11,402
+1,579
| +16% | +$79.1K | 0.01% | 653 |
|
|
2020
Q3 | $413K | Buy |
+9,823
| New | +$413K | 0.01% | 739 |
|